196 related articles for article (PubMed ID: 25604717)
1. Malignant medication? Testosterone and cancer.
Pastuszak AW
BJU Int; 2015 Feb; 115(2):179-80. PubMed ID: 25604717
[No Abstract] [Full Text] [Related]
2. Testosterone therapy and cancer risk.
Eisenberg ML; Li S; Betts P; Herder D; Lamb DJ; Lipshultz LI
BJU Int; 2015 Feb; 115(2):317-21. PubMed ID: 24684569
[TBL] [Abstract][Full Text] [Related]
3. The uses and misuses of testosterone therapy.
Johns Hopkins Med Lett Health After 50; 2006 Aug; 18(6):3, 7. PubMed ID: 16921650
[No Abstract] [Full Text] [Related]
4. [Testosterone substitution with special regard to prostate cancer].
Beintker M; Behre H
Urologe A; 2008 Dec; 47(12):1588-91. PubMed ID: 18931991
[TBL] [Abstract][Full Text] [Related]
5. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Coward RM; Simhan J; Carson CC
BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
[TBL] [Abstract][Full Text] [Related]
6. FPIN's clinical inquiries. Testosterone therapy and risk recurrence after treatment of prostate cancer.
Meza J; Weaver K; Martin S
Am Fam Physician; 2013 Oct; 88(8):Online. PubMed ID: 24364582
[No Abstract] [Full Text] [Related]
7. Androgen replacement therapy in aging men.
Katz A
Nurse Pract; 2004 Oct; 29(10):58-64. PubMed ID: 15489672
[No Abstract] [Full Text] [Related]
8. Testosterone replacement therapy for late onset hypogonadism: what is the risk of inducing prostate cancer?
Gould DC; Kirby RS
Prostate Cancer Prostatic Dis; 2006; 9(1):14-8. PubMed ID: 16264770
[TBL] [Abstract][Full Text] [Related]
9. [Risks, contraindications, abuse and monitoring risks of testosterone replacement therapy (TRT)].
Glina S; Wroclawski ER; Chaves OH
Int Braz J Urol; 2006; 32 Suppl 1():31-4. PubMed ID: 23631039
[No Abstract] [Full Text] [Related]
10. [Testosterone and the prostate].
Sperling H; Rossi R; Lümmen G; Rübben H
Urologe A; 2004 Sep; 43(9):1092-6. PubMed ID: 15368045
[TBL] [Abstract][Full Text] [Related]
11. Jatenzo - an oral testosterone for hypogonadism.
Med Lett Drugs Ther; 2021 Jun; 63(1627):103-104. PubMed ID: 34181633
[No Abstract] [Full Text] [Related]
12. [Testosterone replacement therapy for hypogonadism in men with prostate cancer].
Jensen CF; Fode M; Østergren P; Sønksen J
Ugeskr Laeger; 2017 Feb; 179(9):. PubMed ID: 28263152
[TBL] [Abstract][Full Text] [Related]
13. Testosterone may speed up the growth of prostate cancer due to aromatase activity.
Friedman AE
BJU Int; 2010 Aug; 106(3):434. PubMed ID: 20653657
[No Abstract] [Full Text] [Related]
14. [Hypogonadism - testosterone replacement therapy after prostate cancer?].
van Essen J; Pfister D; Heidenreich A
Aktuelle Urol; 2014 Jan; 45(1):17-8. PubMed ID: 24500954
[No Abstract] [Full Text] [Related]
15. [Testosterone replacement therapy and prostate cancer: the downfall of a paradigm?].
Castillo OA; López-Fontana G; Vidal-Mora I; López Laur JD
Medwave; 2015 Apr; 15(3):e6115. PubMed ID: 25919660
[TBL] [Abstract][Full Text] [Related]
16. [The bear is sleeping, the bear is sleeping...].
Borre M
Ugeskr Laeger; 2017 Jul; 179(30):. PubMed ID: 28789763
[No Abstract] [Full Text] [Related]
17. A new testosterone gel (fortesta) for hypogonadism.
Med Lett Drugs Ther; 2011 Apr; 53(1362):29-30. PubMed ID: 21502933
[TBL] [Abstract][Full Text] [Related]
18. Safety of androgen therapy in men with prostate cancer.
Rajan P; Tharakan T; Chen R
Best Pract Res Clin Endocrinol Metab; 2022 Sep; 36(5):101628. PubMed ID: 35248487
[TBL] [Abstract][Full Text] [Related]
19. [Abdominal pain and hypertension in a 55-year-old male patient].
Kofler T; Yueksel F; Dirnhofer S; Donath MY; Trendelenburg M
Internist (Berl); 2017 Apr; 58(4):397-401. PubMed ID: 28005140
[TBL] [Abstract][Full Text] [Related]
20. Emerging medication for the treatment of male hypogonadism.
Aydogdu A; Swerdloff RS
Expert Opin Emerg Drugs; 2016 Sep; 21(3):255-66. PubMed ID: 27552127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
